{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ7fwaUIDA","lastupdate":"2024-12-07T00:00:00.000Z","update_date":"2024-12-07T00:00:00.000Z","lastModified":"Feb 3, 2025","active":1,"confidence_score":100,"confidence_score_reason":"markets","urlname":"ossio","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$nXSPC65ypHCzzj3xZ6blbiPKWQsWyJuwO5O2oR59aqNCQsqqHAit7L","name":"OSSIO","oneliner":"Intelligent Bone Implant Technology","registrar":"515104503","website":"https://ossio.io","careerspage":"","founded_month":7,"founded_year":2014,"formernames":["Resorbium"],"sociallinks":{"twitter":"https://twitter.com/OSSIOfiber","youtube":"https://www.youtube.com/channel/UC6B6PiDwku9QCx7_XpqfH9g","facebook":"https://www.facebook.com/healbonebetter","linkedin":"https://www.linkedin.com/company/10639272","instagram":""},"social":["https://twitter.com/OSSIOfiber","https://www.youtube.com/channel/UC6B6PiDwku9QCx7_XpqfH9g","https://www.facebook.com/healbonebetter","https://www.linkedin.com/company/10639272"],"flattenedsociallinks":"https://twitter.com/OSSIOfiber|https://www.youtube.com/channel/UC6B6PiDwku9QCx7_XpqfH9g|https://www.facebook.com/healbonebetter|https://www.linkedin.com/company/10639272","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"51-200","employees_exact":139,"patent":1,"raised":90060000,"stage":"D","public_stage":"D","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["osio"],"about":"OSSIO is an orthopedic company providing an innovative alternative to metal implants in the more than $10 billion orthopedic fixation market with its intelligent bone implant technology.\r\n\r\nOSSIOfiber is a biofriendly implant material that is stronger than cortical bone and leaves nothing permanent behind. Stemming from years of biomechanical research and a vision for the possibility of better bone healing, OSSIOfiber is engineered to provide the strength required for functional fixation and allows for full integration into the native anatomy without adverse inflammation. \r\n\r\nOSSIOs proprietary technology can address many surgical applications through the manufacture of endless implant designs. In addition, OSSIOfiber implants utilize existing reimbursement and surgical techniques.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97249986600","country":null,"address":{"israeli":[{"id":"c9c166bd-0c7c-4d46-8295-886c529b5d1c","city":"Caesarea","type":null,"address":"HaTohen Street 8, Caesarea, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"50698e1a-5146-4f29-b0bb-788f9840bd21","city":"Woburn","address":"300 Tradecenter Drive, Woburn, MA, USA","country":"United States","placeid":null}]},"headquarter_address":null,"district":"Center District","news":[{"id":"KegvII7MMq14XiiLqnlT2BgtreRVnmM0RABaQ2LowC2Sd1CGNF57V7","date":"Dec 2, 2024","link":"https://www.businesswire.com/news/home/20241202376882/en/OSSIO-Raises-27.6-Million-to-Accelerate-Its-Commercial-Engine-as-High-Demand-for-Bio-Integrative-Fixation-Technology-Continues","source":"www.businesswire.com","visible":1,"analysis":null,"sentiment":null,"analysisId":"OHEisRRcqkpHNKw5OJLH0zN2HSbC5eq7G8XqvUdaG30Kd9d6oAuPTS","news_summary":"OSSIO Raises $27.6 Million to Accelerate Its Commercial Engine as High Demand for Bio-Integrative Fixation Technology Continues","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"none"},{"id":"UODZzY2toCKXWtSApqVFMDyfSGVcvw57NdHkQXe2jCHkCDD3FDVWDP","date":"Oct 18, 2022","link":"https://www.finsmes.com/2022/10/ossio-closes-38-5m-series-c-financing.html","source":"www.finsmes.com","visible":1,"analysis":{"tags":"Series C Financing","company":"Ossio","layoffs":null,"summary":"Ossio, an orthopedic fixation technology company, has raised $38.5M in Series C funding led by MVM Partners. The funding will be used to strengthen awareness for the patient benefits of OSSIOfiber implants and accelerate new product platforms in the major orthopedic fixation markets. Ossio leverages the OSSIOfiber Intelligent Bone Regeneration Technology to create implants made from a proprietary mineral fiber matrix held together by a naturally degradable polymer. The company has already used over 10,000 OSSIOfiber implants in orthopedic surgeries since 2019.","partners":null,"customers":null,"investors":"MVM Partners","confidence":9,"key_topics":["Ossio","Series C Financing","Orthopedic fixation technology","OSSIOfiber implants","Bio-integrative material properties"],"date_of_event":"2022-10-18","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$38.5M","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"gBYOcdvBix1CUaqAbMsM7ouctrfXf8r1onbN9qeqI3fD0EDJt46FUT","news_summary":"Ossio Closes $38.5M Series C Financing","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"CmV2nfa00qDWK5OLJpica7pcwjDs8KjXC7OtV3zZqgctnfRDUpbg0n","date":"Aug 8, 2022","link":"https://www.businesswire.com/news/home/20220808005202/en/OSSIO-Announces-U.S.-Launch-and-First-Commercial-Use-of-OSSIOfiber%C2%AE-Suture-Anchors-Expanding-Patient-Access-to-Growing-Portfolio-of-Bio-Integrative-Orthopedic-Fixation-Technology","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"e1PnCENzmwIu9qfXJEX1cyOSJBU8CoJEtCRtGTAjPPTKEULYP6DZDU","news_summary":"OSSIO Announces U.S. Launch and First Commercial Use of OSSIOfiber® Suture Anchors, Expanding Patient Access to Growing Portfolio of Bio-Integrative Orthopedic Fixation Technology","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"fHB9aKI4CuKwNlzj4AuWU9dtu2uiHhGERUmCRIzX7CL8xatgxdXhfv","date":"Mar 29, 2022","link":"https://www.businesswire.com/news/home/20220329005599/en/OSSIO-Achieves-Third-FDA-Clearance-in-4-Months-for-OSSIOfiber%C2%AE-Implants-Prepares-to-Expand-Patient-Access-to-Bio-Integrative-Orthopedic-Fixation-Technology-Portfolio-in-Q2Q3","source":"www.businesswire.com","visible":1,"analysis":{"tags":"Regulatory Clearance, Market Expansion","company":"OSSIO","layoffs":"Not Mentioned","summary":"Orthopedic fixation technology start-up OSSIO has received its third regulatory clearance from the U.S. Food and Drug Administration (FDA) for its OSSIOfiber product family. The clearance will allow the company to expand patient and surgeon access to additional implants made from OSSIOfiber Intelligent Bone Regeneration Technology over the next six months. The company has already achieved significant market penetration in the United States, with more than 6,000 implantations of OSSIOfiber products performed to date. The recent FDA clearances are expected to increase the uptake of OSSIOs growing portfolio of bio-integrative products.","partners":"Not Mentioned","customers":"Patients, Surgeons, Providers, Payors","investors":"Not Mentioned","confidence":9,"key_topics":"FDA Clearance, Orthopedic Technology, Market Penetration, Product Launch, Bone Regeneration","date_of_event":"March 29, 2022","valuation_amount":"Not Mentioned","impact_on_company":"Growth-Positive","investment_amount":"Not Mentioned","structured_issues":"Customers, Expand","acquisition_amount":"Not Mentioned","structuredIssuesShow":"#Customers, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"Growth-Positive","analysisId":"l2uskskpkbadbrcwcD9S0jg0OB8SYfdevUfUGwJ6VkS9O6xmwJely3","news_summary":"OSSIO Achieves Third FDA Clearance in 4 Months for OSSIOfiber® Implants; Prepares to Expand Patient Access to Bio-Integrative Orthopedic Fixation Technology Portfolio in Q2/Q3","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"nJa12yRE8EdrPoN0mv39AjfndHzSTkuOqEFMcO7L2MND7GpBxGPyEd","date":"Mar 3, 2022","link":"https://www.odtmag.com/contents/view_breaking-news/2022-03-03/ossio-wins-gpo-contract-for-bio-integrative-fixation-tech/","source":"www.odtmag.com","visible":1,"analysis":{"tags":"expansion","company":"OSSIO Inc.","layoffs":null,"summary":"OSSIO Inc. has expanded its OSSIOfiber product line through a three-year contract with Vizient. The contract enables increased access to OSSIOfiber technology for thousands of U.S. hospitals and surgery centers. The OSSIOfiber products are designed for rapid bone in-growth, regeneration, and replacement, providing durable fixation and natural healing. The contract covers the OSSIOfiber Intelligent Bone Regeneration Technology portfolio, including hammertoe fixation systems, trimmable fixation nails, and compression screws. The products are now available to all members of Vizient at negotiated pricing. OSSIO aims to provide a credible replacement to metal implants in the orthopedic fixation market.","partners":["Vizient"],"customers":null,"investors":null,"confidence":9,"key_topics":["contract","OSSIOfiber","Vizient","healthcare providers","bio-integrative fixation products"],"date_of_event":"2022-03-01","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"g16ymf7yiQFSPhrv7XhqGz9M5Rmq18Md9qme1nSAbUh6zfsxY3fay8","news_summary":"OSSIO Wins GPO Contract for Bio-Integrative Fixation Tech","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"0efacaa8-871b-4c4a-ad02-f596ab40a65f","date":"Mar 13, 2020","link":"https://www.medicaldevice-network.com/news/ossio-bio-integrative-hammertoe-fixation-system/","source":"www.medicaldevice-network.com","visible":1,"analysis":{"tags":"orthopaedic fixation","company":"Ossio","layoffs":null,"summary":"Orthopaedic fixation company Ossio has received FDA 510(k) market clearance for its OSSIOfiber Hammertoe Fixation System, which maintains alignment and fixation of bone fractures, arthrodesis, osteotomies, and bone grafts. The system, designed in three sizes, utilizes a proprietary natural mineral fiber matrix and bio-integrative material properties to provide a biologically friendly way to restore stability and mobility for patients. Ossio plans to launch the hammertoe fixation system and other OSSIOfiber products over the next year. The companys CEO expressed confidence in achieving excellent clinical outcomes and high surgeon and patient satisfaction. Ossio conducted a multi-center clinical trial in Europe to assess the safety and performance of the system, with positive findings expected to support CE Mark approval later this year.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["FDA clearance","OSSIOfiber Hammertoe Fixation System","bio-integrative implants","OSSIOfiber Intelligent Bone Regeneration Technology","European multi-centre study"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Qzy30xz170lboiVSjERwRsl8e7ox0Ssb8Ns7IAHFnE7cMYuEGik9Ai","news_summary":"Ossio gets FDA clearance for OSSIOfiber Hammertoe Fixation System","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"3d398ee1-0a19-42dc-8854-aa2cc31d9a8a","date":"Jun 11, 2019","link":"https://www.businesswire.com/news/home/20190611005301/en/OSSIO-Receives-Prestigious-Frost-Sullivan-New-Product","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"f0zCPYi6W2g9ZDnk3r6maPS8u8jr4pISALYVH3DF5iMN6deeaJGZRp","news_summary":"OSSIO Receives Prestigious Frost & Sullivan New Product Innovation Award for its Breakthrough OSSIOfiberTM Intelligent Bone Regeneration Technology","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"884324a8-b219-45db-8eb3-4483bd224d79","date":"May 16, 2019","link":"https://www.businesswire.com/news/home/20190516005173/en/OSSIO-Announces-U.S.-Launch-Commercial-New-OSSIOfiberTM","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"vyOC9GYNknns9eYArtUAV4jTgUH3LVLGNy32JPLmmuSYlFnziwkUoe","news_summary":"OSSIO Announces U.S. Launch and First Commercial Use of the New OSSIOfiberTM Bone Pin for Hammertoe Correction","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"49ebc74c-6d7a-4204-aff6-05bd95975d08","date":"Mar 11, 2019","link":"https://www.businesswire.com/news/home/20190311005189/en/OSSIO-Secures-22-Million-Financing","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"hoANlJbQG7wDEtJxQVQsaoFMB81SgbetJmEyLvCJLcppjx0aAIAGjz","news_summary":"OSSIO Secures $22 Million in Financing","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"53e711f7-812e-4e40-884b-5b09210eec68","date":"Jun 27, 2018","link":"https://www.beckersspine.com/orthopedic-a-spine-device-a-implant-news/item/41636-ossio-prepares-for-us-market-entrance-with-new-headquarters-4-details.html","source":"www.beckersspine.com","visible":1,"analysis":{"tags":"Expansion, Technology","company":"Ossio","layoffs":"N/A","summary":"Ossio, an orthopedic technology company, is preparing to enter the U.S. market this year. The company has established its U.S. corporate headquarters in Woburn, Massachusetts. Ossios CEO, Brian Verrier, has previously operated out of Cummings Executive Suites in Woburn and Beverly, Massachusetts, and has been building up the companys U.S. presence and staff. The companys new lease is for a 3,000-square-foot office at a Cummings Properties business campus. Ossios proprietary OSSIOfiber Intelligent Bone Regeneration technology is an implant used to heal fractured bone.","partners":"N/A","customers":"N/A","investors":"N/A","confidence":9,"key_topics":["U.S. Expansion","Bone Regeneration Technology"],"date_of_event":"2018","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":["Expand"],"acquisition_amount":"N/A","structuredIssuesShow":"#Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"05bejCCj2n4Irpdee9tC910Nilz9kD4ABglMO1s6Glit3IAb56As2r","news_summary":"Ossio prepares for US market entrance with new headquarters - 4 details","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":10,"techcommunityinvolvement":null,"mediagallery":[{"id":"7a86c6a9-74c5-4406-b6de-bfd135c4d5ec","timestamp":"2018-07-19 12:24:26.000000","resources_type":2,"resources_title":"Ossio","resources_file_name":"QhiHflP1nGE","alt":"Ossio logo","imageurl":"https://img.youtube.com/vi/QhiHflP1nGE/0.jpg","url":"http://youtu.be/QhiHflP1nGE"}],"tags":["orthopedics","surgeons","biomaterials","patent-pending","doctors","healthcare-providers","hospitals","rehabilitation","regenerative-medicine","medical-products","clinics","surgery","medical-technologies"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Released","products":["OSSIOfiber"],"geomarkets":["United States"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":7,"lastfunding":"$27.6M","totalrounds":4,"fundingstage":"D","totalfunding":"$90.06M","publicinvestors":7,"lastpublicfunding":27600000,"totalpublicrounds":3,"totalpublicfunding":88100000},"team":[{"name":"Brian Verrier","email":"brian@ossio.io","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoNqZo6wIDA","bounced":false,"claimed":0,"founder":0,"urlname":"brian-verrier","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg2tmc2wkM","position":"CEO","last_name":"Verrier","claimtoken":"rL6nkWxHGpgZiVoRPlblSfQdrz5vpb7MZyHnW7QkQRNwoGeNCa4jhP","first_name":"Brian","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/brian-verrier-1265a39/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-12-23 16:17:25.000000","initials":"BV","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Orahn Preiss-Bloom ","email":"orahn@ossio.io","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwOyEzoAJDA","bounced":false,"claimed":0,"founder":1,"urlname":"orahn-preiss-bloom-2","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDA7KLOjQoM","position":"Founder & CIO","last_name":"Preiss-Bloom ","claimtoken":"WhqxcgxrvNGnQsq2hGdUwIujJG8b1iIg3OYtZJKCrqUMJdYmuqwbGN","first_name":"Orahn","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/orahn-preiss-bloom-873b8118/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2022-12-23 16:17:27.000000","initials":"OP","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Adina Friedman","email":"adina@ossio.io","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoOXyqawIDA","bounced":false,"claimed":1,"founder":0,"urlname":"adina-friedman","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICglfe7-ggM","position":"Executive Assistant and HR coordinator","last_name":"Friedman","claimtoken":"4ff6bde33b66dff6fa736bb677ca312e4cae60f5705b3ded05cbd18b5e936bec","first_name":"Adina","picturekey":"$MmXaGiTq6p4A25YiLEcMeGnwYI1yYCKHfawR9dbPWqrzBKCX1864qI","claimeddate":"2018-07-31","linkedinurl":"https://www.linkedin.com/in/adina-friedman-66b84419","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2018-07-31 11:19:17.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$MmXaGiTq6p4A25YiLEcMeGnwYI1yYCKHfawR9dbPWqrzBKCX1864qI","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgN7UwIEIDA","fullname":"Aviv Alper"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMHXnNsIDA","fullname":"Jenny Sotnik-Talisman"},"biverifydate":"2020-05-31T00:00:00.000Z","crunchbaseid":"ossio","lastupdator":"Matan Eblagon","lastupdator_email":"matane@sncentral.org","creator":"Rachel Wain","creator_email":"rachelwain18@gmail.com","createdate":"2015-01-11T00:00:00.000Z","biverification":"Jenny Sotnik-Talisman","sectorverification":"Aviv Alper","affiliatedOrganizations":null,"timeline":[{"id":"t6hCIZD8SGankpjnKBjv3mYThyuTKh9giRPU5x2jZGvstimxmax6AE","date":"Dec 2024","amount":"$27.6M","source":"https://www.businesswire.com/news/home/20241202376882/en/OSSIO-Raises-27.6-Million-to-Accelerate-Its-Commercial-Engine-as-High-Demand-for-Bio-Integrative-Fixation-Technology-Continues","eventtype":"FundingRoundEvent","investment":[{"name":"Questa Capital","type":"Investor","amount":null,"hidden":true,"country":"United States","fullurl":"/investor_page/questa-capital","logokey":"$4c1G4qTFlw6Pdyno3hZIubEY3L5TUdJPdZpUv20YoT9fdWQTFRBFKi.jpeg","tagline":null,"urlname":"/investor_page/questa-capital","isisraeli":0,"investorid":"iGV6C9JxyB6FiebvW7mXvwMRt4OM8Kmgwf2nc2u6YV4tkCcvTmys6f","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"5P0QVIIZnoT2bb7FbpLJPeEzeZx4mXC4IAabS2nwVrDLvgEXD1eWMt","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$4c1G4qTFlw6Pdyno3hZIubEY3L5TUdJPdZpUv20YoT9fdWQTFRBFKi.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"MVM Life Science Partners","type":"Investor","amount":null,"hidden":false,"country":"United Kingdom","fullurl":"/investor_page/mvm-life-science-partners","logokey":"$ebb7pzb9dSUV3Xa3ibeLzwK3R82RKWpBZOoKtTU8BFQVOBPYqEdOci","tagline":"","urlname":"/investor_page/mvm-life-science-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCk8POsCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"8KauCvj7wgozwyDmkBwSTCwnTCbQsFVcjIpTmtWOZRirSDHLJKOTxD","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ebb7pzb9dSUV3Xa3ibeLzwK3R82RKWpBZOoKtTU8BFQVOBPYqEdOci","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":" Courage Capital","type":"Investor","amount":null,"hidden":true,"country":"United States","fullurl":"/investor_page/-courage-capital","logokey":"$shf8uZ0rmb2qeBbnGFtXamFQMmLOL2BeSSga1Mbp9XuDmFcBXAvuxI.jpeg","tagline":null,"urlname":"/investor_page/-courage-capital","isisraeli":0,"investorid":"HfVPBgJln1LQa2GruPNgR3JQIlrVB4E5Qf0taQc3qsR1D4RrgVP9Kx","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"FlRExIWkSjxQcSqBTAjhMN2XzMJjDbrCHben6LedpjxRfzdLqx1vc6","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$shf8uZ0rmb2qeBbnGFtXamFQMmLOL2BeSSga1Mbp9XuDmFcBXAvuxI.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"OCV Partners","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/ocv-partners","logokey":"$6s2RjKq9JqJ8lLvVxiidCJIEYWNS7B8dDUKHmTunWYDJ2jQDDLy52V.jpeg","tagline":"","urlname":"/investor_page/ocv-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCi-5mHCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"iTxFQQX9Mswa3ojKf7h7gNEOhedX0t5aNNeOzpWTfam0XLBHtpWZZC","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$6s2RjKq9JqJ8lLvVxiidCJIEYWNS7B8dDUKHmTunWYDJ2jQDDLy52V.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"D Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":27600000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"GzE1eKxkh0gvRBrzNjhnY8YBELztMJzzWucel2ZKZngXhkiKoneHJq","date":"Oct 2022","amount":"$38.5M","source":"https://www.finsmes.com/2022/10/ossio-closes-38-5m-series-c-financing.html, https://www.ourcrowd.com/myportfolio/opportunities/ossio?utm_campaign=OurCrowd%20Weekly%20Newsletter&utm_medium=email&utm_content=286823122&utm_source=hs_email","eventtype":"FundingRoundEvent","investment":[{"name":"MVM Life Science Partners","type":"Investor","amount":null,"hidden":false,"country":"United Kingdom","fullurl":"/investor_page/mvm-life-science-partners","logokey":"$ebb7pzb9dSUV3Xa3ibeLzwK3R82RKWpBZOoKtTU8BFQVOBPYqEdOci","tagline":"","urlname":"/investor_page/mvm-life-science-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCk8POsCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"PSMOsnjIt8DLt4wSiyA9XlVEjfp3qcDmZdkNqbHDicvt9JmOfVAxJO","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ebb7pzb9dSUV3Xa3ibeLzwK3R82RKWpBZOoKtTU8BFQVOBPYqEdOci","leadcaption":"","followupcaption":""},{"name":"OurCrowd","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/ourcrowd","logokey":"$7IbHrXXd8dSbWrifZtvAYNCvwQvEjxCgGJeOg7DXKENs3TbpV3W9g1","tagline":null,"urlname":"/investor_page/ourcrowd","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7H-oQKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"lgBiyYBhBbP0Y92zGbid5IJZidkQQRSuajT0zCv1Q6miF4l6qWBR5b","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$7IbHrXXd8dSbWrifZtvAYNCvwQvEjxCgGJeOg7DXKENs3TbpV3W9g1","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"C Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":38500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODCsevKCQw","date":"Mar 2019","amount":"$22M","source":"https://www.businesswire.com/news/home/20190311005189/en/OSSIO-Secures-22-Million-Financing","eventtype":"FundingRoundEvent","investment":[{"name":"OCV Partners","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/ocv-partners","logokey":"$6s2RjKq9JqJ8lLvVxiidCJIEYWNS7B8dDUKHmTunWYDJ2jQDDLy52V.jpeg","tagline":"","urlname":"/investor_page/ocv-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCi-5mHCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"JUoujAV1Dg8cdaUWuS2rvNjozRE46pEo1vnjmWF8XbFeQOQpqE9clK","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$6s2RjKq9JqJ8lLvVxiidCJIEYWNS7B8dDUKHmTunWYDJ2jQDDLy52V.jpeg","leadcaption":"","followupcaption":""},{"name":"Secocha Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/secocha-ventures","logokey":"$5RK3DrLoe23bADJiCDaip3lQOhClzYp11CcP3CFBEyEwe25Klk9a6C","tagline":"","urlname":"/investor_page/secocha-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODEnNzNCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"JVAsXMnWqvt8paaNqH6KKTXjCWUNkZxASDwssnOkja3LHHrA6oMrRa","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5RK3DrLoe23bADJiCDaip3lQOhClzYp11CcP3CFBEyEwe25Klk9a6C","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Ortho Vision LLC","type":"Company","amount":0,"hidden":true,"country":"United States","fullurl":"/company_page/ortho-vision-llc","logokey":null,"tagline":"","urlname":"/company_page/ortho-vision-llc","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCSrK_BCgw","fundingtype":"Company","leadpartner":null,"investmentid":"M53iAkusLxjBJpHu8OKkY54o3mWlollN3vuD7eAlnr98QX3Zyr0PyN","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/startups-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":22000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEzfzpCww","date":"May 2016","amount":"$1.96M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Secocha Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/secocha-ventures","logokey":"$5RK3DrLoe23bADJiCDaip3lQOhClzYp11CcP3CFBEyEwe25Klk9a6C","tagline":"","urlname":"/investor_page/secocha-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODEnNzNCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"V5mfBynQQER0pSoU41R72IWLpnUF7QJ39gg6RsRsRoYTCj27rJps2B","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5RK3DrLoe23bADJiCDaip3lQOhClzYp11CcP3CFBEyEwe25Klk9a6C","leadcaption":"Lead&nbsp;","followupcaption":""}],"eventvisibility":"Internal","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Internal</text>\n</div>'","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1960000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"7/2014","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"OSSIO","logourl":"https://storage.googleapis.com/clean-finder-353810/$nXSPC65ypHCzzj3xZ6blbiPKWQsWyJuwO5O2oR59aqNCQsqqHAit7L","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$nXSPC65ypHCzzj3xZ6blbiPKWQsWyJuwO5O2oR59aqNCQsqqHAit7L","seoabout":"OSSIO is an orthopedic company providing an innovative alternative to metal implants in the more than $10 billion orthopedic fixation market with its intel...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":2,"name":"Implants","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationDelimited":["TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA>Implants#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"classificationsViewModel":"|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA|2:>TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA/Implants#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Medical Devices","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Treatment & Therapeutics","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]}],"coreTechnology":[{"title":"Materials & Substances","key":"0-0","path":"TechnologyClassificationModel>Materials & Substances","children":[{"title":"Implants","key":"0-0-0","path":"TechnologyClassificationModel>Materials & Substances>Implants"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":2,"name":"Implants","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Medical Devices","Medical Treatment & Therapeutics"],"coreTechnology":["Materials & Substances","Implants"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"t6hCIZD8SGankpjnKBjv3mYThyuTKh9giRPU5x2jZGvstimxmax6AE","date":"Dec 2024","amount":"$27.6M","source":"https://www.businesswire.com/news/home/20241202376882/en/OSSIO-Raises-27.6-Million-to-Accelerate-Its-Commercial-Engine-as-High-Demand-for-Bio-Integrative-Fixation-Technology-Continues","eventtype":"FundingRoundEvent","investment":[{"name":"Questa Capital","type":"Investor","amount":null,"hidden":true,"country":"United States","fullurl":"/investor_page/questa-capital","logokey":"$4c1G4qTFlw6Pdyno3hZIubEY3L5TUdJPdZpUv20YoT9fdWQTFRBFKi.jpeg","tagline":null,"urlname":"/investor_page/questa-capital","isisraeli":0,"investorid":"iGV6C9JxyB6FiebvW7mXvwMRt4OM8Kmgwf2nc2u6YV4tkCcvTmys6f","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"5P0QVIIZnoT2bb7FbpLJPeEzeZx4mXC4IAabS2nwVrDLvgEXD1eWMt","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$4c1G4qTFlw6Pdyno3hZIubEY3L5TUdJPdZpUv20YoT9fdWQTFRBFKi.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"MVM Life Science Partners","type":"Investor","amount":null,"hidden":false,"country":"United Kingdom","fullurl":"/investor_page/mvm-life-science-partners","logokey":"$ebb7pzb9dSUV3Xa3ibeLzwK3R82RKWpBZOoKtTU8BFQVOBPYqEdOci","tagline":"","urlname":"/investor_page/mvm-life-science-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCk8POsCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"8KauCvj7wgozwyDmkBwSTCwnTCbQsFVcjIpTmtWOZRirSDHLJKOTxD","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ebb7pzb9dSUV3Xa3ibeLzwK3R82RKWpBZOoKtTU8BFQVOBPYqEdOci","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":" Courage Capital","type":"Investor","amount":null,"hidden":true,"country":"United States","fullurl":"/investor_page/-courage-capital","logokey":"$shf8uZ0rmb2qeBbnGFtXamFQMmLOL2BeSSga1Mbp9XuDmFcBXAvuxI.jpeg","tagline":null,"urlname":"/investor_page/-courage-capital","isisraeli":0,"investorid":"HfVPBgJln1LQa2GruPNgR3JQIlrVB4E5Qf0taQc3qsR1D4RrgVP9Kx","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"FlRExIWkSjxQcSqBTAjhMN2XzMJjDbrCHben6LedpjxRfzdLqx1vc6","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$shf8uZ0rmb2qeBbnGFtXamFQMmLOL2BeSSga1Mbp9XuDmFcBXAvuxI.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"OCV Partners","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/ocv-partners","logokey":"$6s2RjKq9JqJ8lLvVxiidCJIEYWNS7B8dDUKHmTunWYDJ2jQDDLy52V.jpeg","tagline":"","urlname":"/investor_page/ocv-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCi-5mHCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"iTxFQQX9Mswa3ojKf7h7gNEOhedX0t5aNNeOzpWTfam0XLBHtpWZZC","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$6s2RjKq9JqJ8lLvVxiidCJIEYWNS7B8dDUKHmTunWYDJ2jQDDLy52V.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"D Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":27600000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"GzE1eKxkh0gvRBrzNjhnY8YBELztMJzzWucel2ZKZngXhkiKoneHJq","date":"Oct 2022","amount":"$38.5M","source":"https://www.finsmes.com/2022/10/ossio-closes-38-5m-series-c-financing.html, https://www.ourcrowd.com/myportfolio/opportunities/ossio?utm_campaign=OurCrowd%20Weekly%20Newsletter&utm_medium=email&utm_content=286823122&utm_source=hs_email","eventtype":"FundingRoundEvent","investment":[{"name":"MVM Life Science Partners","type":"Investor","amount":null,"hidden":false,"country":"United Kingdom","fullurl":"/investor_page/mvm-life-science-partners","logokey":"$ebb7pzb9dSUV3Xa3ibeLzwK3R82RKWpBZOoKtTU8BFQVOBPYqEdOci","tagline":"","urlname":"/investor_page/mvm-life-science-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCk8POsCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"PSMOsnjIt8DLt4wSiyA9XlVEjfp3qcDmZdkNqbHDicvt9JmOfVAxJO","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ebb7pzb9dSUV3Xa3ibeLzwK3R82RKWpBZOoKtTU8BFQVOBPYqEdOci","leadcaption":"","followupcaption":""},{"name":"OurCrowd","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/ourcrowd","logokey":"$7IbHrXXd8dSbWrifZtvAYNCvwQvEjxCgGJeOg7DXKENs3TbpV3W9g1","tagline":null,"urlname":"/investor_page/ourcrowd","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7H-oQKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"lgBiyYBhBbP0Y92zGbid5IJZidkQQRSuajT0zCv1Q6miF4l6qWBR5b","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$7IbHrXXd8dSbWrifZtvAYNCvwQvEjxCgGJeOg7DXKENs3TbpV3W9g1","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"C Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":38500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODCsevKCQw","date":"Mar 2019","amount":"$22M","source":"https://www.businesswire.com/news/home/20190311005189/en/OSSIO-Secures-22-Million-Financing","eventtype":"FundingRoundEvent","investment":[{"name":"OCV Partners","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/ocv-partners","logokey":"$6s2RjKq9JqJ8lLvVxiidCJIEYWNS7B8dDUKHmTunWYDJ2jQDDLy52V.jpeg","tagline":"","urlname":"/investor_page/ocv-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCi-5mHCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"JUoujAV1Dg8cdaUWuS2rvNjozRE46pEo1vnjmWF8XbFeQOQpqE9clK","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$6s2RjKq9JqJ8lLvVxiidCJIEYWNS7B8dDUKHmTunWYDJ2jQDDLy52V.jpeg","leadcaption":"","followupcaption":""},{"name":"Secocha Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/secocha-ventures","logokey":"$5RK3DrLoe23bADJiCDaip3lQOhClzYp11CcP3CFBEyEwe25Klk9a6C","tagline":"","urlname":"/investor_page/secocha-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODEnNzNCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"JVAsXMnWqvt8paaNqH6KKTXjCWUNkZxASDwssnOkja3LHHrA6oMrRa","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5RK3DrLoe23bADJiCDaip3lQOhClzYp11CcP3CFBEyEwe25Klk9a6C","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Ortho Vision LLC","type":"Company","amount":0,"hidden":true,"country":"United States","fullurl":"/company_page/ortho-vision-llc","logokey":null,"tagline":"","urlname":"/company_page/ortho-vision-llc","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCSrK_BCgw","fundingtype":"Company","leadpartner":null,"investmentid":"M53iAkusLxjBJpHu8OKkY54o3mWlollN3vuD7eAlnr98QX3Zyr0PyN","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/startups-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":22000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEzfzpCww","date":"May 2016","amount":"$1.96M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Secocha Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/secocha-ventures","logokey":"$5RK3DrLoe23bADJiCDaip3lQOhClzYp11CcP3CFBEyEwe25Klk9a6C","tagline":"","urlname":"/investor_page/secocha-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODEnNzNCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"V5mfBynQQER0pSoU41R72IWLpnUF7QJ39gg6RsRsRoYTCj27rJps2B","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5RK3DrLoe23bADJiCDaip3lQOhClzYp11CcP3CFBEyEwe25Klk9a6C","leadcaption":"Lead&nbsp;","followupcaption":""}],"eventvisibility":"Internal","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Internal</text>\n</div>'","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1960000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}